Table 3.
Univariable logistic regression analyses of precystoscopy predictors of bladder malignancy during hematuria evaluation
| Variable | Odds ratio | 2.50% | 97.50% | p value |
|---|---|---|---|---|
| Age (per 1 year) | 1.015 | 0.97 | 1.064 | 0.519 |
| Male sex | 1.013 | 0.248 | 3.568 | 0.984 |
| Blood thinner use | 1.188 | 0.392 | 3.897 | 0.766 |
| History of prostatic hypertrophy | 0.447 | 0.064 | 1.935 | 0.331 |
| History of urothelial cancer | 0.689 | 0.096 | 3.209 | 0.662 |
| History of pelvic radiation | 1.294 | 0.168 | 7.289 | 0.777 |
| History of prostate cancer | 2.812 | 0.479 | 16.6 | 0.233 |
| Neutrophil count | 1.063 | 0.9 | 1.254 | 0.459 |
| Lymphocyte count | 0.785 | 0.37 | 1.279 | 0.452 |
| Platelet count | 1 | 0.994 | 1.006 | 0.931 |
| NLR | 1 | 0.883 | 1.108 | 0.998 |
| PLR | 0.999 | 0.994 | 1.005 | 0.806 |
NLR, neutrophil lymphocyte ratio; PLR, platelet lymphocyte ratio.